Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depend on the ability to deliver tiny particles known as aerosols to the correct location in ...
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their ...
A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ...
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC)1 and OXB,1 today announce the start of LENTICLAIRTM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, gene ...
A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...
Researchers are tackling neutrophilic asthma, successfully developing one of the first mouse models of the condition.
A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...
Individuals with asthma and chronic obstructive pulmonary disease (COPD) were more vulnerable than healthy controls to ...
Xilio Therapeutics (XLO) announced three wholly-owned preclinical programs for masked T cell engagers targeting prostate-specific membrane ...
This study examines the EMT process in human bronchial epithelial cells (HBECs) from non-smokers, smokers and patients with COPD as well as the in vitro effect of cigarette smoke extract (CSE) on EMT.
umcg.nl Background We hypothesised that increased oxidative stress, as present in the airways of asthma and chronic obstructive pulmonary disease (COPD) patients, induces epithelial damage and reduces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback